Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1

被引:65
|
作者
Yedavalli, VSRK
Benkirane, M
Jeang, KT
机构
[1] NIAID, Mol Microbiol Lab, Mol Virol Sect, Bethesda, MD 20892 USA
[2] CNRS, Unite Propre Rech, Inst Genet Humaine, Lab Virol Mol & Transfert Gene, F-34296 Montpellier, France
关键词
D O I
10.1074/jbc.M209162200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-TEFb, cyclin T1 + CDK9, is needed for the expression of cellular promoters and primate lentiviral long terminal repeats (LTRs). Curiously, cellular and lentiviral promoters differ dramatically in the requirements for positive transcriptional elongation factor (P-TEF) b activity. Lentiviral LTRs, but not cellular promoters, need an RNA-associated P-TEFb/Tat/TAR (trans-activation-responsive) RNA ternary complex. Ternary complex defective murine cycT1 is apparently inactive for lentiviral transcription. Why P-TEFb requires Tat/TAR for LTRs but not for cellular promoters remains unknown. To explore this question, we sought to determine whether DNA targeting of murine and human cyclin T1 can reconstitute a Tat/TAR-independent activity to the HIV-1 LTR. In the absence of Tat and TAR, we found that both HuCycT1 and MuCycT1 can robustly activate the HIV-1 LTR. We further showed that Sp1 is necessary and sufficient for this DNA-targeted activity. Thus, like cellular promoters, HIV-1 LTR can use P-TEFb function without a Tat/TAR RNA complex. This activity could explain recent findings of robust HIV-1 replication in rat cells that cannot form a P-TEFb/Tat/TAR moiety.
引用
收藏
页码:6404 / 6410
页数:7
相关论文
共 50 条
  • [1] HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1
    Zhang, J
    Tamilarasu, N
    Hwang, SW
    Garber, ME
    Huq, I
    Jones, KA
    Rana, TM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34314 - 34319
  • [2] Binding of phage-displayed HIV-1 Tat to TAR RNA in the presence of cyclin T1
    Jonas, G
    Hoffmann, S
    Willbold, D
    JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (05) : 430 - 436
  • [3] HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN BINDS TRANS-ACTIVATION-RESPONSIVE REGION (TAR) RNA INVITRO
    DINGWALL, C
    ERNBERG, I
    GAIT, MJ
    GREEN, SM
    HEAPHY, S
    KARN, J
    LOWE, AD
    SINGH, M
    SKINNER, MA
    VALERIO, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) : 6925 - 6929
  • [4] TAR-INDEPENDENT ACTIVATION OF HIV-1 REQUIRES THE ACTIVATION DOMAIN BUT NOT THE RNA-BINDING DOMAIN OF TAT
    TAYLOR, JP
    KUNDU, M
    KHALILI, K
    VIROLOGY, 1993, 195 (02) : 780 - 785
  • [5] HIV-1 TAT TRANS-ACTIVATION REQUIRES THE LOOP SEQUENCE WITHIN TAR
    FENG, S
    HOLLAND, EC
    NATURE, 1988, 334 (6178) : 165 - 167
  • [6] Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat
    Bieniasz, PD
    Grdina, TA
    Bogerd, HP
    Cullen, BR
    EMBO JOURNAL, 1998, 17 (23): : 7056 - 7065
  • [7] HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA
    Garber, ME
    Wei, P
    Jones, KA
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1998, 63 : 371 - 380
  • [8] Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA
    Mestre, B
    Arzumanov, A
    Singh, M
    Boulmé, F
    Litvak, S
    Gait, MJ
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1445 (01): : 86 - 98
  • [9] The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
    Garber, ME
    Wei, P
    KewalRamani, VN
    Mayall, TP
    Herrmann, CH
    Rice, AP
    Littman, DR
    Jones, KA
    GENES & DEVELOPMENT, 1998, 12 (22) : 3512 - 3527
  • [10] Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
    Kwak, YT
    Ivanov, D
    Guo, J
    Nee, E
    Gaynor, RB
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 288 (01) : 57 - 69